Table 14 Summary of prevalence of side effects for the four MPPT countries
From: Mass primaquine treatment to eliminate vivax malaria: lessons from the past
Country | Assessment | G6PD prevalence (%) | Treated (N) | Side effects (%) | Serious side effects (*) |
|---|---|---|---|---|---|
Geokchai, Azerbaijan | Daily field reports | 12-38 | 30,000 | 2-4 | 7 persons |
Mirbashir, Azerbaijan | Surveys | 5-10 | 3,000 | 2.7 | 0 |
North Afghanistan | Surveys | 0-15 | 94,000 | A few cases | 0 |
Tajikistan | Daily reports | 0.8-4 | 1,374,000 | A few cases | 0 |
DPR Korea | Daily field reports | 2.9 | 7,000,000 | 1.5-4 | A few cases |